This is the first study to follow serial lymphocyte subsets, serum immunoglobulins (IgG, IgA and IgM), CRP, and complements (C3 and C4) levels in patients with brain tumors treated with neurosurgical tumor resection and to correlate the findings with postoperative infection complication. This evidence concerns the gene CD79A and brain neoplasm.